Skip to content

Q4 FY26 Earnings Results

Q4 FY26 earnings, Jan–Mar 2026: 5,781 Indian listed companies have reported; median profit growth is +5.8% on last year, and 220 of 401 companies with analyst estimates beat them. Quarter ended 31 Mar 2026.

Q1Q2Q3Q4
Reported
5,781
companies
Profit breadth
52% / 45%
grew / declined · 4,024 comparable
Median sales YoY
+11.8%
across all reporters
Median profit YoY
+5.8%
across all reporters
Beat / missed
220 / 145
of 401 covered
Strongest / weakest
Energy +44.0%
Commodities −59.7%
median profit growth, 10+ reporters
LargestFastest profit growthFastest sales growthBiggest beatsBiggest misses
Clear filters 1–100 of 270
CompanyRevenue (₹ Cr)Profit (₹ Cr)Per share8Q profit
Symbol Sector Reported YoY QoQ Reported YoY EPS vs consensus Trend
SUNPHARMA Sun Pharmaceutical Industries LtdHealthcare14,612up+12.8%down−5.9%2,710up+25.8%11.31In line +1.5% est. 11.13
AUROPHARMA Aurobindo Pharma LtdHealthcare8,853up+5.6%up+2.4%921up+2.0%15.86Miss −3.4% est. 16.42
ZYDUSLIFE Zydus Lifesciences LtdHealthcare7,587up+16.2%up+10.5%1,341up+7.8%12.65Beat +48.4% est. 8.52
DRREDDY Dr Reddys Laboratories LtdHealthcare7,546down−11.5%down−13.8%221down−86.1%2.65Miss −76.3% est. 11.18
LUPIN Lupin LtdHealthcare7,475up+31.9%up+4.3%1,469up+87.9%31.94Beat +30.8% est. 26.62
CIPLA Cipla LtdHealthcare6,541down−2.8%down−7.5%543down−55.3%6.87Miss −29.0% est. 9.68
BIOCON Biocon LtdHealthcare4,517up+2.3%up+8.2%199down−56.6%0.78Miss −33.6% est. 1.19
TORNTPHARM Torrent Pharmaceuticals LtdHealthcare4,197up+41.8%up+27.1%364down−26.9%10.76Miss −45.5% est. 21.10
GLENMARK Glenmark Pharmaceuticals LtdHealthcare3,771up+15.8%down−3.3%301up+7,425.0%10.68No estimate
ALKEM Alkem Laboratories LtdHealthcare3,603up+14.6%down−3.6%251down−22.0%19.78Miss −65.3% est. 56.90
MANKIND Mankind Pharma LtdHealthcare3,443up+11.8%down−3.5%559up+31.5%13.43Beat +26.3% est. 10.64
DIVISLAB Divis Laboratories LtdHealthcare2,831up+9.5%up+8.7%751up+13.4%28.29Beat +8.5% est. 26.10
PPLPHARMA Piramal Pharma LtdHealthcare2,752down−0.1%up+28.6%−9down−105.8%−0.07Miss −107.4% est. 0.95
EMCURE Emcure Pharmaceuticals LtdHealthcare2,470up+16.7%up+4.5%244up+23.9%12.84Beat +2.7% est. 12.50
IPCALAB Ipca Laboratories LtdHealthcare2,388up+6.3%down−0.2%307up+379.7%11.79Beat +46.3% est. 9.10
JUBLPHARMA Jubilant Pharmova LtdHealthcare2,290up+18.7%up+7.9%119down−21.2%7.50No estimate
SPARC Sun Pharma Advanced Research Company LtdHealthcare1,853up+6,763.0%up+23,062.5%1,761n/a54.26No estimate
APLLTD Alembic Pharmaceuticals LtdHealthcare1,848up+4.4%down−1.5%202up+28.7%10.31Beat +22.7% est. 8.40
LAURUSLABS Laurus Labs LtdHealthcare1,812up+5.3%up+1.9%282up+21.0%5.17Beat +2.9% est. 5.02
GLAND Gland Pharma LtdHealthcare1,743up+22.3%up+2.8%367up+96.3%22.26Beat +51.4% est. 14.70
ABBOTINDIA Abbott India LtdHealthcare1,710up+6.5%down−0.8%395up+7.6%185.86No estimate
GRANULES Granules India LtdHealthcare1,471up+22.9%up+6.0%202up+32.9%8.13Beat +17.6% est. 7.00
AJANTPHARM Ajanta Pharma LtdHealthcare1,422up+21.5%up+3.4%267up+18.7%21.35Beat +2.4% est. 20.85
STAR Strides Pharma Science LtdHealthcare1,323up+11.2%up+10.7%129up+50.0%13.77No estimate
AKUMS Akums Drugs & Pharmaceuticals LtdHealthcare1,158up+9.7%down−0.2%81down−46.0%5.38No estimate
SYNGENE Syngene International LtdHealthcare1,037up+1.8%up+13.0%148down−19.3%3.67Beat +92.7% est. 1.91
INDGN Indegene LtdHealthcare1,003up+32.7%up+6.5%80down−32.2%3.31Miss −29.4% est. 4.70
GLAXO Glaxosmithkline Pharmaceuticals LtdHealthcare995up+2.2%down−4.4%278up+5.7%16.40No estimate
MANIPALHOS Manipal Health Enterprises LtdHealthcare967n/an/a92n/a0.78No estimate
WOCKPHARMA Wockhardt LtdHealthcare965up+29.9%up+8.7%164n/a10.22No estimate
VIYASH Viyash Scientific LtdHealthcare920up+128.9%up+7.2%66up+560.0%1.19No estimate
JBCHEPHARM J B Chemicals & Pharmaceuticals LtdHealthcare904down−4.7%down−15.1%101down−30.8%6.31No estimate
MARKSANS Marksans Pharma LtdHealthcare856up+20.9%up+13.5%149up+63.7%3.27No estimate
DCAL Dishman Carbogen Amcis LtdHealthcare851up+18.9%up+18.2%22down−48.8%1.39No estimate
NEULANDLAB Neuland Laboratories LtdHealthcare776up+136.6%up+76.4%213up+660.7%165.76Beat +112.1% est. 78.16
ERIS ERIS Lifesciences LtdHealthcare757up+7.4%down−6.2%279up+173.5%20.33Beat +106.0% est. 10.00
NATCOPHARM Natco Pharma LtdHealthcare739down−39.5%up+14.2%269down−33.7%13.65No estimate
AARTIDRUGS Aarti Drugs LtdHealthcare720up+6.4%up+19.6%55down−12.7%6.05No estimate
ALIVUS Alivus Life Sciences LtdHealthcare689up+6.0%up+2.4%163up+14.8%13.25Miss −57.3% est. 31.00
PFIZER Pfizer LtdHealthcare629up+6.3%down−2.5%200down−39.6%43.68Beat +7.9% est. 40.50
COHANCE Cohance Lifesciences LtdHealthcare619down−26.3%up+13.6%8down−93.2%0.51Miss −65.1% est. 1.46
IOLCP IOL Chemicals & Pharmaceuticals LtdHealthcare619up+17.2%up+6.7%53up+65.6%1.81No estimate
ANTHEM Anthem Biosciences LtdHealthcare611up+26.5%up+44.4%190up+128.6%3.38No estimate
SAILIFE Sai Life Sciences LtdHealthcare602up+3.8%up+8.3%104up+18.2%4.92In line −0.4% est. 4.95
CAPLIPOINT Caplin Point Laboratories LtdHealthcare600up+19.5%up+10.5%173up+19.3%22.38No estimate
FDC FDC LtdHealthcare585up+18.9%up+25.8%103up+164.1%6.35No estimate
AARTIPHARM Aarti Pharmalabs LtdHealthcare583up+3.4%up+35.0%61down−30.7%6.74No estimate
ASTRAZEN Astrazeneca Pharma India LtdHealthcare579up+20.6%down−5.4%45down−22.4%17.95No estimate
UNICHEMLAB Unichem Laboratories LtdHealthcare575down−2.0%up+10.4%11down−79.2%1.55No estimate
POLYMED Poly Medicure LtdHealthcare535up+21.3%up+8.3%65down−29.3%6.54Miss −16.2% est. 7.80
HIKAL Hikal LtdHealthcare519down−6.0%up+5.1%14down−71.3%1.17No estimate
RUBICON Rubicon Research LtdHealthcare514up+43.6%up+8.0%77up+113.9%4.65Beat +14.1% est. 4.10
MOREPENLAB Morepen Laboratories LtdHealthcare485up+4.1%up+0.2%16down−20.0%0.29No estimate
INDOCO Indoco Remedies LtdHealthcare476up+22.1%up+7.0%−24n/a−2.34Beat +32.4% est. −3.80
SANOFI Sanofi India LtdHealthcare472down−11.9%up+12.4%103down−14.2%44.61No estimate
REMUS Remus Pharmaceuticals LtdHealthcare453up+30.2%n/a25up+19.0%16.54No estimate
INNOVACAP Innova Captab LtdHealthcare448up+42.2%down−0.5%40up+34.5%6.65No estimate
MOLBIO Molbio Diagnostics LtdHealthcare439n/an/a66n/a5.83No estimate
SHILPAMED Shilpa Medicare LtdHealthcare437up+32.0%up+6.6%108up+620.0%5.51No estimate
ACUTAAS Acutaas Chemicals LtdHealthcare433up+40.6%up+10.2%134up+112.7%16.09No estimate
ONESOURCE OneSource Specialty Pharma LtdHealthcare428up+0.5%up+47.6%5down−94.9%0.40No estimate
SOLARA Solara Active Pharma Sciences LtdHealthcare387up+41.8%up+10.9%10n/a2.65No estimate
PGHL Procter & Gamble Health LtdHealthcare370up+19.0%down−1.1%95up+55.7%56.99No estimate
ORCHPHARMA Orchid Pharma LtdHealthcare368up+55.1%up+77.7%26up+15.9%5.09No estimate
CORONA Corona Remedies LtdHealthcare353up+20.1%up+3.2%45up+45.2%7.37Beat +15.8% est. 6.40
CONCORDBIO Concord Biotech LtdHealthcare326down−24.2%up+17.3%90down−36.6%8.60No estimate
RUBRAMEDICAMENTSLTD Centuple Global LtdHealthcare279up+1,11,664.0%up+60.5%0down−900.0%−0.88No estimate
SUPRIYA Supriya Lifescience LtdHealthcare277up+50.5%up+34.5%74up+48.0%9.22No estimate
VENUSREM Venus Remedies LtdHealthcare259up+32.8%up+43.9%48up+128.6%35.54No estimate
BLISSGVS Bliss GVS Pharma LtdHealthcare257up+29.8%up+17.9%37up+117.6%3.36No estimate
GUFICBIO Gufic BioSciences LtdHealthcare252up+22.9%up+9.1%21up+162.5%2.05No estimate
SYMBIOTEC Symbiotec Pharmalab LtdHealthcare245n/an/a28n/a4.39No estimate
SYMBIOTEC Symbiotec Pharmalab LtdHealthcare245n/an/a28n/a4.39No estimate
SMSPHARMA SMS Pharmaceuticals LtdHealthcare238down−4.0%up+13.3%33up+65.0%3.49No estimate
WINDLAS Windlas Biotech LtdHealthcare238up+17.2%up+2.1%160.0%7.59No estimate
BLUEJET Blue Jet Healthcare LtdHealthcare235down−30.9%up+22.4%64down−41.8%3.71Beat +42.7% est. 2.60
KOPRAN Kopran LtdHealthcare234up+35.8%up+20.5%19up+94.9%3.91No estimate
SANOFICONR Sanofi Consumer Healthcare India LtdHealthcare229up+32.4%down−8.8%68up+36.0%29.44No estimate
SYSCHEMINDIALTD Syschem (India) LtdHealthcare219up+84.5%up+55.0%2up+278.3%0.36No estimate
JSLL Jeena Sikho Lifecare LtdHealthcare216up+55.4%down−2.7%45up+80.0%3.65No estimate
FREDUN Fredun Pharmaceuticals LtdHealthcare213up+27.5%up+32.3%11up+57.1%6.75No estimate
ADVENZYMES Advanced Enzyme Technologies LtdHealthcare203up+21.6%up+18.0%45up+66.7%3.84No estimate
ANUHPHR Anuh Pharma LtdHealthcare202up+2.0%up+2.5%120.0%1.17No estimate
QLINE Q-Line Biotech LtdHealthcare198down−8.8%n/a34up+277.8%21.14No estimate
SAIPARENT Sai Parenterals LtdHealthcare198n/aup+105.9%13n/a2.98No estimate
AAREYDRUGS Aarey Drugs & Pharmaceuticals LtdHealthcare189up+75.3%up+96.5%2up+231.9%0.55No estimate
BI Bilcare LtdHealthcare188down−3.1%up+3.9%8down−33.3%5.68No estimate
LINCOLN Lincoln Pharmaceuticals LtdHealthcare187up+11.3%up+12.7%120.0%5.81No estimate
SUDEEPPHRM Sudeep Pharma LtdHealthcare182up+15.2%up+5.8%49up+11.4%4.33No estimate
RPGLIFE RPG Life Sciences LtdHealthcare177up+23.8%down−1.7%30down−74.4%18.08No estimate
SENORES Senores Pharmaceuticals LtdHealthcare175up+53.5%up+2.3%37up+105.6%6.86No estimate
INDSWFTLAB Ind-Swift Laboratories LtdHealthcare170up+23.2%up+12.6%15down−93.2%1.74No estimate
HEMANTSURGICALINDUSTRIESLTD Healthcare167up+187.9%n/a13up+160.0%9.84No estimate
WANBURY Wanbury LtdHealthcare165down−4.3%up+1.3%22up+7.1%6.21No estimate
ZOTA Zota Health Care LtdHealthcare163up+68.0%up+14.0%−14n/a−4.09No estimate
FABTECH Fabtech Technologies LtdHealthcare159up+17.5%up+152.6%22up+46.2%4.96No estimate
KPL Kwality Pharmaceuticals LtdHealthcare157up+35.3%up+27.6%25up+78.6%24.38No estimate
BAJAJHCARE Bajaj Healthcare LtdHealthcare153down−0.6%down−5.0%−23down−309.1%−6.79No estimate
AMRUTANJAN Amrutanjan Health Care LtdHealthcare150up+10.6%up+6.2%16up+6.7%5.60No estimate
NGLFINE NGL Fine Chem LtdHealthcare149up+60.5%up+18.4%13n/a18.37No estimate

About Q4 FY26 earnings data

When are Q4 FY26 results announced?
Q4 FY26 covers the Jan–Mar 2026 quarter. Indian listed companies have up to 45 days after a quarter closes to file their results — 60 days for the January–March quarter — so results arrive in a wave over the weeks that follow rather than all at once. A quarter that has only just ended will look sparse and fill in.
Why do some Q4 FY26 growth figures show "n/a" instead of a percentage?
Growth is left blank whenever the comparison period was not profitable. A percentage change measured from a loss is arithmetic without meaning — a swing from a ₹10 crore loss to a ₹10 crore profit is not "200% growth", and publishing it as such would flatter the company. The reported figures for both periods are still shown, so the change is there to read directly.
Does the beat/miss verdict cover every company?
No, and the denominator matters. An analyst consensus existed for 401 of the 5,781 companies that reported Q4 FY26 — 6.9%. Beat, missed and in-line describe only those. Every other company is marked "no estimate" rather than being counted as in line, because nobody forecast it. Revenue and profit growth, by contrast, cover every company in the table.
What counts as an in-line result rather than a beat or a miss?
Reported earnings per share within ±2% of the consensus estimate. The band is set there because a tighter one classifies rounding as news, and a wider one swallows surprises that genuinely moved a stock.
Are the figures consolidated or standalone?
Consolidated where a company reports on that basis, standalone otherwise, with all money in ₹ crore. Figures are as filed by the company with the exchanges (NSE/BSE); they are not restated or adjusted.
What does the 8-quarter trend line show?
Quarterly net profit for the last eight quarters, oldest on the left, always ending on the quarter shown in the row. Two years covers both the seasonal shape of the business and its direction. The line breaks where a quarter is missing rather than drawing across the gap, so a break is a real absence of data and not a reported collapse.
How do I find only the companies that beat estimates in Q4 FY26?
Use the Result filter above the table and choose Beat, or sort by EPS surprise to rank every covered company by how far it landed from consensus. Both are reflected in the page URL, so a filtered view can be bookmarked or shared.

Figures are as reported by companies in their quarterly filings to the exchanges (NSE/BSE), in ₹ crore. Consolidated results are shown where a company reports them, otherwise standalone. Year-on-year and quarter-on-quarter growth is omitted where the comparison period was loss-making, since a percentage change from a negative base is not meaningful. Analyst consensus is an estimate, not a forecast of outcome.